Glycosides in medicine: "The role of glycosidic residue in biological activity".
about
The structural biology of enzymes involved in natural product glycosylationStructural basis for C-ribosylation in the alnumycin A biosynthetic pathwayEnzymatic methods for glyco(diversification/randomization) of drugs and small moleculesIn Silico and In Vitro Analysis of Bacoside A Aglycones and Its Derivatives as the Constituents Responsible for the Cognitive Effects of Bacopa monnieriFunctional screening of metagenome and genome libraries for detection of novel flavonoid-modifying enzymesCharting biologically relevant chemical space: a structural classification of natural products (SCONP)Ethnobotany as a pharmacological research tool and recent developments in CNS-active natural products from ethnobotanical sources.Natural-product sugar biosynthesis and enzymatic glycodiversification.Spirotetronate polyketides as leads in drug discovery.Creation of the first anomeric D/L-sugar kinase by means of directed evolutionA functional genomics approach to (iso)flavonoid glycosylation in the model legume Medicago truncatula.A strategy for cloning glycosyltransferase genes involved in natural product biosynthesis.Scaffold diversity of natural products: inspiration for combinatorial library design.In vitro characterization of the enzymes involved in TDP-D-forosamine biosynthesis in the spinosyn pathway of Saccharopolyspora spinosa.Mining of efficient microbial UDP-glycosyltransferases by motif evolution cross plant kingdom for application in biosynthesis of salidroside.Characterization of the TDP-D-ravidosamine biosynthetic pathway: one-pot enzymatic synthesis of TDP-D-ravidosamine from thymidine-5-phosphate and glucose-1-phosphate.Mechanistic studies of the biosynthesis of 2-thiosugar: evidence for the formation of an enzyme-bound 2-ketohexose intermediate in BexX-catalyzed reactionCharacterization of TDP-4-keto-6-deoxy-D-glucose-3,4-ketoisomerase from the D-mycaminose biosynthetic pathway of Streptomyces fradiae: in vitro activity and substrate specificity studiesSulfation of dietary flavonoids by human sulfotransferases.Mechanisms and structures of vitamin B(6)-dependent enzymes involved in deoxy sugar biosynthesis.Multidrug efflux pumps from Enterobacteriaceae, Vibrio cholerae and Staphylococcus aureus bacterial food pathogensTLC and HPTLC Fingerprints of Various Secondary Metabolites in the Stem of the Traditional Medicinal Climber, Solena amplexicaulisHighly efficient and enzymatic regioselective undecylenoylation of gastrodin in 2-methyltetrahydrofuran-containing systems.The effects of marine carbohydrates and glycosylated compounds on human health.Structure-based enzyme engineering and its impact on in vitro glycorandomization.Synthetic Strategies Toward the Decalin Motif of Maklamicin and Related Spirotetronates.Biosynthetic pathway toward carbohydrate-like moieties of alnumycins contains unusual steps for C-C bond formation and cleavage.Metabolic engineering of Escherichia coli into a versatile glycosylation platform: production of bio-active quercetin glycosides.Dose Dependent Dual Effect of Baicalin and Herb Huang Qin Extract on Angiogenesis.Construction of the octose 8-phosphate intermediate in lincomycin A biosynthesis: characterization of the reactions catalyzed by LmbR and LmbN.A comparison of sugar indicators enables a universal high-throughput sugar-1-phosphate nucleotidyltransferase assay.Elucidation of the kijanimicin gene cluster: insights into the biosynthesis of spirotetronate antibiotics and nitrosugars.Engineered biosynthesis of macrolide derivatives bearing the non-natural deoxysugars 4-epi-D-mycaminose and 3-n-monomethylamino-3-deoxy-D-fucose.Occurrence, biological activities and synthesis of kaurane diterpenes and their glycosides.Engineering Saccharomyces cerevisiae with the deletion of endogenous glucosidases for the production of flavonoid glucosides.Probing 3-hydroxyflavone for in vitro glycorandomization of flavonols by YjiC.In vitro characterization of LmbK and LmbO: identification of GDP-D-erythro-α-D-gluco-octose as a key intermediate in lincomycin A biosynthesis.Efficacy and mechanism of a glycoside compound inhibiting abnormal prion protein formation in prion-infected cells: implications of interferon and phosphodiesterase 4D-interacting protein.Marine glycobiology: current status and future perspectives.The transaldolase family: new synthetic opportunities from an ancient enzyme scaffold.
P2860
Q26824482-6ED67743-DCCF-4EB2-A4F0-B69223E525CAQ27675804-41ACBA00-9F7E-4863-A910-9303DD6FD271Q28247479-3B4D102F-33C2-447F-B0A5-539461CEDF2EQ28547187-FC9F1A27-24C9-418F-B250-907BB0ABEE79Q28675597-457E75E3-D9B2-4BDC-B3C5-7F0FA3A1D3CFQ30351855-7A36C1B0-7A29-4F2F-A62B-BE7177036C14Q30396823-6BEBB106-245F-4917-B24F-E6E0441E9BA9Q30492476-35D461FA-91E8-478D-9363-FC0762549CC2Q30872494-FF931A08-9CD3-4020-99B5-E0ACF23C580FQ33194952-7A8813CF-DB12-4D28-A87B-7DE6C1938B69Q33282192-AAE2E780-D05F-461C-B781-8C1B13243B8CQ33284411-1063D083-DC3B-46A4-B9EB-F9408A362B9EQ33372355-97C6C382-098A-45ED-AC9C-0920997895D8Q33618888-F4FC422D-595A-4ECA-8F6A-679D35C9889DQ33673165-2C8A5DC3-BF1E-4B8E-8CFB-B1A27C7C550AQ34160676-E279F8D5-DC38-48F6-8B36-C97A806D2C43Q34284443-7515C7E0-91BD-4834-A573-725D39D42F38Q34599243-514D42F1-DD91-4788-9F9A-EA172C650AF0Q35020036-64B5F639-4FDD-4456-928E-5CD5FF205910Q35046495-9F481452-792A-44D7-BDCC-1144E82E18D9Q35131669-F9AF26BC-22CC-4DEC-83A6-774220F986C9Q35166217-1D098BED-D396-4C95-BBC2-B50F727D3436Q35348425-0721AA92-75DB-491F-82B8-BBB02E25274BQ35381522-FC5FC3B4-8E7E-4A71-AD73-16EB6264C520Q35616313-6536418D-493B-4D57-B650-80D99F4BCCB5Q35924404-2E8EEED8-1759-4A12-8DE6-086B980971E1Q35924920-254DEF10-F1D6-4044-894A-B8041E1AF1A3Q36068827-1D7BAB39-F37A-475A-967F-C1C19ED29C25Q36208194-7DD517EE-F307-4E98-A4D7-4A6CB29456D1Q36365002-C7D1967C-CCE2-4230-9EF1-0028C0DBF756Q36742059-E8A831CC-EA59-43C8-96F8-15070356EB4AQ36835457-A7C77790-FA7E-4D58-9CEB-3D192B213289Q36835476-FE9BCD48-AB55-44E6-BAE5-7A3F964D86A2Q36939225-971379B7-A5D2-4893-BDCD-0DD0EE97D0EDQ37151976-B7D54DC0-7E17-4C41-9097-B6E145DC2B8FQ37263980-6B812C38-798D-470A-969F-0F81ED67A9FFQ37598129-109906E3-C5B2-4CAE-9B98-A82E731C8402Q37713907-47A0672F-A4EA-44E6-A7BF-B5F8DD87CE0DQ37730587-F7950F96-574F-420C-BAD6-4D9AD559C829Q37875830-4798D46F-5844-40BD-AF7A-715DC8F2E5A2
P2860
Glycosides in medicine: "The role of glycosidic residue in biological activity".
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Glycosides in medicine: "The role of glycosidic residue in biological activity".
@ast
Glycosides in medicine: "The role of glycosidic residue in biological activity".
@en
Glycosides in medicine: "The role of glycosidic residue in biological activity".
@nl
type
label
Glycosides in medicine: "The role of glycosidic residue in biological activity".
@ast
Glycosides in medicine: "The role of glycosidic residue in biological activity".
@en
Glycosides in medicine: "The role of glycosidic residue in biological activity".
@nl
prefLabel
Glycosides in medicine: "The role of glycosidic residue in biological activity".
@ast
Glycosides in medicine: "The role of glycosidic residue in biological activity".
@en
Glycosides in medicine: "The role of glycosidic residue in biological activity".
@nl
P356
P1476
Glycosides in medicine: "The role of glycosidic residue in biological activity".
@en
P2093
P304
P356
10.2174/0929867013372193
P577
2001-09-01T00:00:00Z